REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 74 filers reported holding REPROS THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $970,000 | -19.9% | 1,001,000 | 0.0% | 0.21% | -8.9% |
| Q4 2015 | $1,211,000 | -85.6% | 1,001,000 | -11.6% | 0.24% | -88.7% |
| Q3 2015 | $8,413,000 | +3.9% | 1,132,367 | 0.0% | 2.08% | +11.5% |
| Q2 2015 | $8,096,000 | -16.8% | 1,132,367 | 0.0% | 1.86% | -9.2% |
| Q1 2015 | $9,727,000 | -13.8% | 1,132,367 | 0.0% | 2.05% | -48.6% |
| Q4 2014 | $11,290,000 | +0.7% | 1,132,367 | 0.0% | 4.00% | -7.7% |
| Q3 2014 | $11,210,000 | -35.4% | 1,132,367 | +12.9% | 4.33% | -26.7% |
| Q2 2014 | $17,358,000 | +74.5% | 1,003,367 | +79.0% | 5.90% | +72.4% |
| Q1 2014 | $9,945,000 | +18.3% | 560,600 | +22.0% | 3.42% | +8.7% |
| Q4 2013 | $8,409,000 | – | 459,508 | – | 3.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Allegis Investment Advisors, LLC | 342,709 | $569,000 | 0.29% |
| GENERAL AMERICAN INVESTORS CO INC | 396,123 | $638,000 | 0.07% |
| Alambic Investment Management, L.P. | 69,191 | $111,000 | 0.03% |
| Acrospire Investment Management LLC | 15,119 | $24,000 | 0.02% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 98,486 | $158,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 315,030 | $507,000 | 0.01% |
| SIMPLEX TRADING, LLC | 86,054 | $138,000 | 0.01% |
| A.R.T. Advisors, LLC | 34,315 | $55,000 | 0.00% |
| Mariner Wealth Advisors-Cincinnati, LLC | 11,000 | $18,000 | 0.00% |
| Renaissance Technologies | 561,713 | $904,000 | 0.00% |